Bafiti, V.; Thanou, E.; Ouzounis, S.; Kotsakis, A.; Georgoulias, V.; Lianidou, E.; Katsila, T.; Markou, A.
Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC. Cancers 2024, 16, 3729.
https://doi.org/10.3390/cancers16223729
AMA Style
Bafiti V, Thanou E, Ouzounis S, Kotsakis A, Georgoulias V, Lianidou E, Katsila T, Markou A.
Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC. Cancers. 2024; 16(22):3729.
https://doi.org/10.3390/cancers16223729
Chicago/Turabian Style
Bafiti, Vivi, Eleni Thanou, Sotiris Ouzounis, Athanasios Kotsakis, Vasilis Georgoulias, Evi Lianidou, Theodora Katsila, and Athina Markou.
2024. "Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC" Cancers 16, no. 22: 3729.
https://doi.org/10.3390/cancers16223729
APA Style
Bafiti, V., Thanou, E., Ouzounis, S., Kotsakis, A., Georgoulias, V., Lianidou, E., Katsila, T., & Markou, A.
(2024). Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC. Cancers, 16(22), 3729.
https://doi.org/10.3390/cancers16223729